EUVIMEDEUVIMED entdecken
Crossref

METTL5 Promotes Tumor Progression in Oral Squamous Cell Carcinoma by Activating the Myc Pathway

Rong Huang, Xingyu Feng, Tao Zhou, Jiajing Lu, Ying Wang, Shuangyue Zhang, Wei Zhang

Journal of Oral Pathology & Medicine · 2025-02 · 54 (2) · 91-99

DOI: 10.1111/jop.13601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, online erschienen am 27.01.2025. Verfasst von Rong Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Taizhou Polytechnic College, Taizhou, Jiangsu Province, China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Methyltransferases, Proto-Oncogene Proteins c-myc, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: The Science and Technology Development Fund of Nanjing Medical University, The academy level scientific research project of Taizhou Polytechnic College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It has been observed that methyltransferases‐like 5 (METTL5) is a key mediator underlying tumorigenesis in humans. This study aimed to investigate the biological function, expression pattern, and clinical significance of METTL5 in oral squamous cell carcinoma (OSCC).

Methods

Bioinformatics interrogations and immunohistochemical staining were utilized for determining the expression and localization of METTL5 in OSCC, and revealing the relationship between the expression of METTL5 and prognosis. Cell phenotype experiments and xenograft models were used to detect the impact of METTL5 silencing on OSCC. Gene Set Enrichment Analysis, Spearman correlation, and c‐Myc overexpression plasmid was utilized for exploring the regulatory effects of METTL5 on the Myc pathway.

Results

METTL5 was overexpressed in OSCC and correlated with reduced survival. Cell proliferation, migration, and invasion were significantly inhibited by METTL5 knockdown in vitro, and tumor growth was impaired in vivo. Moreover, METTL5 was capable of activating the Myc pathway. The influences of knockdown of METTL5 on Cal27 cell biological behaviors were reversed by overexpression of c‐Myc.

Conclusions

Our data suggested that METTL5 may act as a putative oncogene and prognostic biomarker in OSCC. The Myc pathway appears to be involved in cell proliferation, migration, invasion, and apoptosis in OSCC mediated by METTL5.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsMethyltransferasesProto-Oncogene Proteins c-mycCarcinoma, Squamous CellHumansDisease ProgressionCell ProliferationAnimalsCell Line, TumorCell MovementSignal TransductionMiceMaleFemaleGene Expression Regulation, NeoplasticPrognosisMiddle AgedMice, NudeNeoplasm Invasiveness

Stichwörter der Autor:innen

METTL5OSCCbiomarkerprognosisthe Myc pathway

Substanzen

MethyltransferasesProto-Oncogene Proteins c-mycMYC protein, human

Autor:innen und Institutionen

  • School of Medicine, Taizhou Polytechnic College, Taizhou, Jiangsu Province, China.
  • The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu Province, China.

Förderung

  • The Science and Technology Development Fund of Nanjing Medical University
  • The academy level scientific research project of Taizhou Polytechnic College

Zitieren

APA

Huang, R., Feng, X., Zhou, T., Lu, J., Wang, Y., Zhang, S., & Zhang, W. (2025). METTL5 Promotes Tumor Progression in Oral Squamous Cell Carcinoma by Activating the Myc Pathway. Journal of Oral Pathology & Medicine, 54(2), 91-99. https://doi.org/10.1111/jop.13601

Vancouver

Huang R, Feng X, Zhou T, Lu J, Wang Y, Zhang S, et al. METTL5 Promotes Tumor Progression in Oral Squamous Cell Carcinoma by Activating the Myc Pathway. Journal of Oral Pathology & Medicine. 2025;54(2):91-99. doi:10.1111/jop.13601

BibTeX
@article{Huang2025,
  author = {Huang, Rong and Feng, Xingyu and Zhou, Tao and Lu, Jiajing and Wang, Ying and Zhang, Shuangyue and Zhang, Wei},
  title = {METTL5 Promotes Tumor Progression in Oral Squamous Cell Carcinoma by Activating the Myc Pathway},
  journal = {Journal of Oral Pathology & Medicine},
  year = {2025},
  volume = {54},
  number = {2},
  pages = {91--99},
  doi = {10.1111/jop.13601}
}
Kostenlos starten →